These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. Moriyama T; Kitamura H; Ochi S; Izumi M; Yokoyama K; Yamauchi A; Ueda N; Kamada T; Imai E J Am Soc Nephrol; 1995 Dec; 6(6):1676-8. PubMed ID: 8749698 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. Haas M; Yilmaz N; Schmidt A; Neyer U; Arneitz K; Stummvoll HK; Wallner M; Auinger M; Arias I; Schneider B; Mayer G Kidney Blood Press Res; 1998; 21(1):66-9. PubMed ID: 9661139 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status. van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415 [TBL] [Abstract][Full Text] [Related]
5. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis]. Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452 [TBL] [Abstract][Full Text] [Related]
6. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension. Zivko M; Kusec R; Galesić K Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214 [TBL] [Abstract][Full Text] [Related]
7. Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism. Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F J Med Genet; 2003 Dec; 40(12):e130. PubMed ID: 14684698 [No Abstract] [Full Text] [Related]
8. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism. Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460 [TBL] [Abstract][Full Text] [Related]
10. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor. Li X; Du Y; Du Y; Huang X J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):25-30. PubMed ID: 12652327 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors in the treatment of sarcoidosis and association with ACE gene polymorphism: case series. Kaura V; Kaura NV; Kaura BN; Kaura CS Indian J Chest Dis Allied Sci; 2013; 55(2):105-7. PubMed ID: 24047001 [TBL] [Abstract][Full Text] [Related]
14. [Gene polymorphisms of renin-angiotensin system in patients with kidney diseases]. Narita I; Gejyo F Nihon Rinsho; 2004 Oct; 62(10):1811-5. PubMed ID: 15500123 [TBL] [Abstract][Full Text] [Related]
15. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811 [TBL] [Abstract][Full Text] [Related]
16. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248 [TBL] [Abstract][Full Text] [Related]
17. ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients. van der Kleij FG; Navis GJ; Gansevoort RT; Heeg JE; Scheffer H; de Zeeuw D; de Jong PE Nephrol Dial Transplant; 1997; 12 Suppl 2():42-6. PubMed ID: 9269699 [TBL] [Abstract][Full Text] [Related]
18. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms. Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats. Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585 [TBL] [Abstract][Full Text] [Related]
20. Personalized arrhythmia prevention: do the I's have it? Davis AM Heart Rhythm; 2014 Apr; 11(4):644-5. PubMed ID: 24389574 [No Abstract] [Full Text] [Related] [Next] [New Search]